Consecutive severe immune-related adverse events after PD-1 inhibitor induction and surgery in locally advanced non-small cell lung cancer: a case report

Neoadjuvant PD-(L)1 inhibitors may be promising for locally advanced non-small cell lung cancer (NSCLC) with potential pathological and survival benefits. But severe immune-related adverse events (irAEs) may cause fatal consequences which require early identification and timely intervention. The bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hang, Ning, Junwei, Gu, Yu, Zhang, Xiaocheng, Yu, Wen, Chen, Tianxiang, Luo, Qingquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435383/
https://www.ncbi.nlm.nih.gov/pubmed/34584866
http://dx.doi.org/10.21037/tlcr-21-603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435383/
https://www.ncbi.nlm.nih.gov/pubmed/34584866
http://dx.doi.org/10.21037/tlcr-21-603

Ejemplares similares